This page has beta status

CMST COST Action CM1407
Challenging organic syntheses inspired by nature - from natural products chemistry to drug discovery

Natural products (NP) have had a major impact on chemistry, chemical biology and drug discovery and have been part of medical remedies since ancient times. Nowadays, NP represent a unique source of leads for medicinal chemistry and drugs derived from NP have found widespread use for the treatment of cancer, cardiovascular diseases, bacterial and fungal infections. The general aim of this COST Action is to advance the field and to maintain the high level of expertise in NP chemistry within Europe by combining synthetic chemistry, computational chemistry, chemical biology, and pharmacology to find new lead structures of pharmaceutical relevance. Since chemistry plays a key role in addressing the industrial requirements for preclinical candidates in terms of physicochemical properties of NP and their analogues, this Action further aims to promote the translation between fundamental academic research and industrial drug discovery by means of NP chemistry.

(Descriptions are provided by the Actions directly via e-COST.)


General Information*

Chair of the Action:

Prof Bruno BOTTA (IT)

Vice Chair of the Action:

Prof Sandra LIEKENS (BE)

Science officer of the Action:

Dr Lucia FORZI

Administrative officer of the Action:

Ms Andrea TORTAJADA

Downloads*

Action Fact Sheet

Download AFS as .RTF

Memorandum of Understanding

Download MoU as PDF

Websites*

Action website:

http://natchemdrugs.eu

* content provided by e-COST.
Data is synchronised once per night.

Tools

Last updated: 19 November 2014 top of page

Follow COST on

  • Twitter
  • LinkedIn
  • Facebook
  • YouTube